• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

实现一项针对糖尿病相关并发症长期风险评估的服务。

Realization of a service for the long-term risk assessment of diabetes-related complications.

作者信息

Lagani Vincenzo, Chiarugi Franco, Manousos Dimitris, Verma Vivek, Fursse Joanna, Marias Kostas, Tsamardinos Ioannis

机构信息

Institute of Computer Science, Foundation for Research and Technology-Hellas, Heraklion, Greece.

Institute of Computer Science, Foundation for Research and Technology-Hellas, Heraklion, Greece.

出版信息

J Diabetes Complications. 2015 Jul;29(5):691-8. doi: 10.1016/j.jdiacomp.2015.03.011. Epub 2015 Mar 25.

DOI:10.1016/j.jdiacomp.2015.03.011
PMID:25953402
Abstract

AIM

We present a computerized system for the assessment of the long-term risk of developing diabetes-related complications.

METHODS

The core of the system consists of a set of predictive models, developed through a data-mining/machine-learning approach, which are able to evaluate individual patient profiles and provide personalized risk assessments. Missing data is a common issue in (electronic) patient records, thus the models are paired with a module for the intelligent management of missing information.

RESULTS

The system has been deployed and made publicly available as Web service, and it has been fully integrated within the diabetes-management platform developed by the European project REACTION. Preliminary usability tests showed that the clinicians judged the models useful for risk assessment and for communicating the risk to the patient. Furthermore, the system performs as well as the United Kingdom Prospective Diabetes Study (UKPDS) Risk Engine when both systems are tested on an independent cohort of UK diabetes patients.

CONCLUSIONS

Our work provides a working example of risk-stratification tool that is (a) specific for diabetes patients, (b) able to handle several different diabetes related complications, (c) performing as well as the widely known UKPDS Risk Engine on an external validation cohort.

摘要

目的

我们展示了一个用于评估糖尿病相关并发症长期风险的计算机化系统。

方法

该系统的核心由一组通过数据挖掘/机器学习方法开发的预测模型组成,这些模型能够评估个体患者概况并提供个性化风险评估。缺失数据是(电子)患者记录中的常见问题,因此这些模型与一个用于智能管理缺失信息的模块相结合。

结果

该系统已作为网络服务进行部署并公开可用,并且已完全集成到欧洲项目REACTION开发的糖尿病管理平台中。初步可用性测试表明,临床医生认为这些模型对于风险评估以及向患者传达风险很有用。此外,当在一组独立的英国糖尿病患者中对这两个系统进行测试时,该系统的表现与英国前瞻性糖尿病研究(UKPDS)风险引擎相当。

结论

我们的工作提供了一个风险分层工具的实际示例,该工具(a)针对糖尿病患者,(b)能够处理几种不同的糖尿病相关并发症,(c)在外部验证队列中的表现与广为人知的UKPDS风险引擎相当。

相似文献

1
Realization of a service for the long-term risk assessment of diabetes-related complications.实现一项针对糖尿病相关并发症长期风险评估的服务。
J Diabetes Complications. 2015 Jul;29(5):691-8. doi: 10.1016/j.jdiacomp.2015.03.011. Epub 2015 Mar 25.
2
Development and validation of risk assessment models for diabetes-related complications based on the DCCT/EDIC data.基于糖尿病控制与并发症试验/糖尿病干预和并发症流行病学研究(DCCT/EDIC)数据的糖尿病相关并发症风险评估模型的开发与验证
J Diabetes Complications. 2015 May-Jun;29(4):479-87. doi: 10.1016/j.jdiacomp.2015.03.001. Epub 2015 Mar 6.
3
The CORE Diabetes Model: Projecting long-term clinical outcomes, costs and cost-effectiveness of interventions in diabetes mellitus (types 1 and 2) to support clinical and reimbursement decision-making.核心糖尿病模型:预测1型和2型糖尿病干预措施的长期临床结局、成本及成本效益,以支持临床和报销决策。
Curr Med Res Opin. 2004 Aug;20 Suppl 1:S5-26. doi: 10.1185/030079904X1980.
4
Validation of the CORE Diabetes Model against epidemiological and clinical studies.针对流行病学和临床研究对CORE糖尿病模型进行验证。
Curr Med Res Opin. 2004 Aug;20 Suppl 1:S27-40. doi: 10.1185/030079904X2006.
5
Diabetes in the Elderly: A Silent Global Tsunami.老年糖尿病:一场无声的全球海啸。
Can J Diabetes. 2016 Feb;40(1):2-3. doi: 10.1016/j.jcjd.2015.12.003. Epub 2016 Jan 6.
6
Validation of the IMS CORE Diabetes Model.IMS核心糖尿病模型的验证
Value Health. 2014 Sep;17(6):714-24. doi: 10.1016/j.jval.2014.07.007.
7
A machine learning-based framework to identify type 2 diabetes through electronic health records.一种基于机器学习的通过电子健康记录识别2型糖尿病的框架。
Int J Med Inform. 2017 Jan;97:120-127. doi: 10.1016/j.ijmedinf.2016.09.014. Epub 2016 Oct 1.
8
What impact would pancreatic beta-cell preservation have on life expectancy, quality-adjusted life expectancy and costs of complications in patients with type 2 diabetes? A projection using the CORE Diabetes Model.胰腺β细胞保护对2型糖尿病患者的预期寿命、质量调整生命预期以及并发症成本会有怎样的影响?使用糖尿病核心模型进行的预测。
Curr Med Res Opin. 2004 Aug;20 Suppl 1:S59-66. doi: 10.1185/030079904X2024.
9
Diabetes Management and Education in Older Adults: The Development of a National Consensus of Key Research Priorities.老年人糖尿病管理和教育:国家关键研究重点共识的制定。
Can J Diabetes. 2016 Feb;40(1):31-4. doi: 10.1016/j.jcjd.2015.08.010. Epub 2015 Nov 23.
10
SMARTDIAB: a communication and information technology approach for the intelligent monitoring, management and follow-up of type 1 diabetes patients.SMARTDIAB:一种用于1型糖尿病患者智能监测、管理及随访的通信和信息技术方法。
IEEE Trans Inf Technol Biomed. 2010 May;14(3):622-33. doi: 10.1109/TITB.2009.2039711. Epub 2010 Jan 29.

引用本文的文献

1
Artificial intelligence in diabetes management: Advancements, opportunities, and challenges.人工智能在糖尿病管理中的应用:进展、机遇与挑战。
Cell Rep Med. 2023 Oct 17;4(10):101213. doi: 10.1016/j.xcrm.2023.101213. Epub 2023 Oct 2.
2
Profiling of patients with type 2 diabetes based on medication adherence data.基于药物依从性数据对 2 型糖尿病患者进行分类。
Front Public Health. 2023 Jul 6;11:1209809. doi: 10.3389/fpubh.2023.1209809. eCollection 2023.
3
Inclusion of Clinicians in the Development and Evaluation of Clinical Artificial Intelligence Tools: A Systematic Literature Review.
临床医生参与临床人工智能工具的开发与评估:一项系统文献综述
Front Psychol. 2022 Apr 7;13:830345. doi: 10.3389/fpsyg.2022.830345. eCollection 2022.
4
Application of multi-label classification models for the diagnosis of diabetic complications.多标签分类模型在糖尿病并发症诊断中的应用。
BMC Med Inform Decis Mak. 2021 Jun 7;21(1):182. doi: 10.1186/s12911-021-01525-7.
5
Role of Artificial Intelligence Applications in Real-Life Clinical Practice: Systematic Review.人工智能应用在实际临床实践中的作用:系统评价
J Med Internet Res. 2021 Apr 22;23(4):e25759. doi: 10.2196/25759.
6
The Need for Ethnoracial Equity in Artificial Intelligence for Diabetes Management: Review and Recommendations.糖尿病管理中人工智能的民族种族公平需求:综述与建议。
J Med Internet Res. 2021 Feb 10;23(2):e22320. doi: 10.2196/22320.
7
Identification of risk factors for patients with diabetes: diabetic polyneuropathy case study.识别糖尿病患者的风险因素:糖尿病多发性神经病病例研究。
BMC Med Inform Decis Mak. 2020 Aug 24;20(1):201. doi: 10.1186/s12911-020-01215-w.
8
Effect of icariside II and metformin on penile erectile function, glucose metabolism, reaction oxygen species, superoxide dismutase, and mitochondrial autophagy in type 2 diabetic rats with erectile dysfunction.淫羊藿苷II和二甲双胍对伴有勃起功能障碍的2型糖尿病大鼠阴茎勃起功能、糖代谢、活性氧、超氧化物歧化酶及线粒体自噬的影响。
Transl Androl Urol. 2020 Apr;9(2):355-366. doi: 10.21037/tau.2020.02.07.
9
Effect of Icariside II and Metformin on Penile Erectile Function, Histological Structure, Mitochondrial Autophagy, Glucose-Lipid Metabolism, Angiotensin II and Sex Hormone in Type 2 Diabetic Rats With Erectile Dysfunction.淫羊藿苷II与二甲双胍对2型糖尿病性勃起功能障碍大鼠阴茎勃起功能、组织结构、线粒体自噬、糖脂代谢、血管紧张素II及性激素的影响
Sex Med. 2020 Jun;8(2):168-177. doi: 10.1016/j.esxm.2020.01.006. Epub 2020 Mar 5.
10
Stacked classifiers for individualized prediction of glycemic control following initiation of metformin therapy in type 2 diabetes.基于堆叠分类器的 2 型糖尿病患者起始二甲双胍治疗后血糖控制个体化预测
Comput Biol Med. 2018 Dec 1;103:109-115. doi: 10.1016/j.compbiomed.2018.10.017. Epub 2018 Oct 16.